HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qianli Ma Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

7/2021LncRNA PCGEM1 induces proliferation and migration in non-small cell lung cancer cells through modulating the miR-590-3p/SOX11 axis.
7/2020Plasma cfDNA as a potential treatment monitoring and prognostic index in patients withnon-small cell lung cancer.
1/2020Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
1/2018The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population.
1/2016How to deal with complicate hilar or interlobar lymphadenopathy during video-assisted thoracoscopic surgery lobectomy.
1/2015The association of adiponectin gene promoter variations with non-small cell lung cancer in a Han Chinese population.
12/2014[A study on the relationship between endoplasmic reticulum aminopeptidase2 genetic polymorphisms and non-small cell lung cancer in Yunnan Han population].
9/2009[Therapeutic efficacy of Traditional Vein Chemotherapy and Bronchial Arterial Infusion Combining with CIKs on III Stage Non-small Cell Lung Cancer.].
4/2003[A clinicopathologic study on neoadjuvant chemotherapy in the treatment of non-small-cell lung cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qianli Ma Research Topics

Disease

19Neoplasms (Cancer)
11/2022 - 04/2010
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 04/2003
7Lung Neoplasms (Lung Cancer)
07/2022 - 02/2010
6Adenocarcinoma of Lung
07/2022 - 12/2020
4Chronic Obstructive Pulmonary Disease (COPD)
07/2021 - 01/2017
4Sickle Cell Anemia (Hemoglobin S Disease)
03/2008 - 01/2005
3Carcinoma (Carcinomatosis)
01/2021 - 01/2017
3Neoplasm Metastasis (Metastasis)
01/2021 - 08/2013
3Asthma (Bronchial Asthma)
07/2019 - 01/2013
3Wounds and Injuries (Trauma)
09/2018 - 08/2010
2Pain (Aches)
12/2022 - 06/2007
2Infections
01/2022 - 02/2011
2Lung Injury
01/2021 - 11/2020
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2020 - 05/2020
1Knee Osteoarthritis
12/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2022
1Stomach Neoplasms (Stomach Cancer)
02/2022
1Hypoxia (Hypoxemia)
01/2022
1Renal Cell Carcinoma (Grawitz Tumor)
12/2021
1acute flaccid myelitis
12/2021
1Periodontitis
11/2021
1Periodontal Diseases (Periodontal Disease)
11/2021
1Chronic Bronchitis
07/2021
1Disease Progression
07/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2021
1Esophageal Squamous Cell Carcinoma
01/2021
1Airway Remodeling
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2020
1Adenocarcinoma
01/2019
1Burns
09/2018
1Hyperthermia
01/2018

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
02/2022 - 07/2021
4MicroRNAs (MicroRNA)IBA
02/2022 - 01/2018
4Transforming Growth Factor beta (TGF-beta)IBA
11/2021 - 06/2006
4GoldIBA
07/2021 - 01/2017
3Cell-Free Nucleic AcidsIBA
11/2022 - 07/2020
3DNA (Deoxyribonucleic Acid)IBA
07/2022 - 03/2007
3Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2021
3Long Noncoding RNAIBA
07/2021 - 01/2020
2RNA (Ribonucleic Acid)IBA
04/2022 - 01/2021
2Peptides (Polypeptides)IBA
12/2021 - 01/2020
2Histocompatibility Antigens Class IIBA
12/2021 - 01/2019
2Biological ProductsIBA
07/2021 - 07/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2020 - 01/2018
2Tiotropium Bromide (Spiriva)FDA Link
07/2019 - 01/2017
2DNA VaccinesIBA
01/2013 - 02/2011
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
03/2007 - 09/2006
1salicylhydroxamic acid (SHAM)IBA
12/2022
1Caspase 3 (Caspase-3)IBA
02/2022
1ribosomal protein L6IBA
02/2022
1Cyclin EIBA
02/2022
1Ribosomal Proteins (Ribosomal Protein)IBA
02/2022
1Oxygen (Dioxygen)IBA
01/2022
1CytokinesIBA
01/2022
1beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
01/2022
1cysteamine dioxygenaseIBA
01/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1DecitabineFDA Link
01/2022
1transporter associated with antigen processing (TAP)IBA
12/2021
1Complement System Proteins (Complement)IBA
12/2021
1AntigensIBA
12/2021
1MetalloproteinsIBA
11/2021
1LipopolysaccharidesIBA
11/2021
1TransducinIBA
07/2021
1Biological FactorsIBA
07/2021
117- (N,N- diisopropylcarbamoyl)estra- 1,3,5(10)- triene- 3- sulfonic acidIBA
01/2021
1Competitive Endogenous RNAIBA
01/2021
1queuine tRNA-ribosyltransferaseIBA
12/2020
1CarbonIBA
11/2020
1SootIBA
11/2020
1Fatty Acids (Saturated Fatty Acids)IBA
10/2020
1Gefitinib (Iressa)FDA Link
07/2020
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
06/2020
1Photosensitizing Agents (Photosensitizers)IBA
06/2020
1azaBDPBA compoundIBA
06/2020
1PolymersIBA
06/2020
1Phosphopyruvate Hydratase (Enolase)IBA
05/2020
1Myelin-Oligodendrocyte GlycoproteinIBA
01/2020
1Small Nucleolar RNA (snoRNA)IBA
01/2020
1Therapeutic UsesIBA
01/2020
1KIR ReceptorsIBA
01/2019
1HLA-C Antigens (HLA-C)IBA
01/2019
1H-cadherin (T-cadherin)IBA
01/2018
1AlbuminsIBA
01/2018

Therapy/Procedure

5Drug Therapy (Chemotherapy)
01/2018 - 04/2003
4Therapeutics
11/2021 - 04/2010
2Phototherapy (Light Therapy)
06/2020 - 01/2018
2Photochemotherapy (Photodynamic Therapy)
06/2020 - 01/2018
2Cryosurgery
07/2016 - 07/2014
2Lymph Node Excision (Lymph Node Dissection)
01/2016 - 01/2016
2Neoadjuvant Therapy
04/2010 - 04/2003
1Intra-Articular Injections
12/2022
1Aftercare (After-Treatment)
01/2022
1Nephrectomy
12/2021
1Photothermal Therapy
06/2020
1Traditional Medicine (Folk Remedies)
09/2018
1Precision Medicine
01/2018
1Intravenous Injections
01/2018